DioVasc by Xymogen – Citrus Bioflavonoid Circulation Support Supplement
DioVasc by Xymogen is a targeted circulation support supplement formulated with highly absorbable citrus bioflavonoids to help maintain healthy blood vessel function and vascular tone. This advanced vascular health supplement features micronized diosmin and hesperidin, compounds traditionally used to support vein health, capillary integrity, and overall circulatory system support. DioVasc offers a convenient way to promote healthy circulation and support vascular comfort as part of a comprehensive wellness routine.
Key DioVasc Benefits
- Supports healthy blood circulation and vascular function
- Helps maintain normal vein health and capillary integrity
- Provides potent citrus bioflavonoids for vascular support
- Promotes healthy vascular tone and circulation
- Helps support overall cardiovascular and circulatory health
How DioVasc Works
DioVasc is formulated with micronized citrus bioflavonoids designed to enhance absorption and deliver targeted support for vascular health and circulation. These plant-derived compounds help maintain blood vessel elasticity, support capillary strength, and promote healthy blood flow throughout the body.
Key ingredients include:
- Micronized Diosmin – A powerful citrus bioflavonoid known to support vein health, vascular tone, and normal circulation. The micronized form improves bioavailability and absorption.
- Hesperidin – A complementary bioflavonoid that supports capillary strength, antioxidant activity, and healthy vascular function.
- Citrus Bioflavonoid Complex – Works synergistically to promote circulatory system support and maintain healthy blood vessel integrity.
This well-tolerated formula is designed to support vascular health with minimal side effects when used as directed.
DioVasc Is Formulated For
DioVasc is designed for individuals looking to support healthy circulation, vascular tone, and vein function. It may be particularly beneficial for those who:
- Want to support healthy blood circulation
- Are seeking a targeted vascular health supplement
- Wish to maintain vein and capillary integrity
- Spend long hours sitting or standing and want circulatory support
- Are interested in plant-based citrus bioflavonoid supplements
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Or you may book a FREE product consultation with Holistic Health Partners. You may want to look at our other Cardiovascular Health products.
Recommendation: Xymogen suggests taking one Diovasc capsule twice daily, or as directed by your healthcare professional.
Serving Size: 1 Capsule
Servings Per Container: 60
Amount Per Serving:
DioVasc Proprietary Blend 500 mg
Micronized diosmin (<4 microns) (from Citrus sinensis) (fruit) and hesperidin (from Citrus sinensis) (fruit)
Other Ingredients: Capsule (hypromellose and water), magnesium stearate, and silica.
Does Not Contain: Wheat, gluten, corn, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.
Storage: Keep closed in a cool, dry place out of reach of children.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518,
References:
- Lyseng-Williamson KA, Perry CM. (2003) Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs;63(1):71-100.
- Ramelet AA. (2001 Aug) Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology;52 Suppl 1:S49-56
- Galley P, Thiollet M. (1993 Mar) A double-blind, placebo-controlled trial of a new venoactive flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility. Int Angiol; 12(1):69-72.
- Behar A, Valensi P, de Champvallins M, et al. (1989 Oct-Dec) Capillary filtration and lymphatic resorption in diabetes. Application to the pharmacodynamic activity of Daflon 500 mg. Int Angiol;8(4 Suppl):27-9.
